AMRN FY 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$307M-16.9% YoY

Gross Profit

$166M53.9% margin

Operating Income

-$68M-22.0% margin

Net Income

-$59M-19.3% margin

EPS (Diluted)

$-3.00

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$832M

Total Liabilities

$280M

Stockholders' Equity

$552M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$307M	$369M	-16.9%
Gross Profit	$166M	$242M	-31.7%
Operating Income	-$68M	-$106M	+36.2%
Net Income	-$59M	-$106M	+44.1%